| Literature DB >> 32069911 |
Abdelilah Mekhloufi1, Andrea Kosta1, Helena Stabile1, Rosa Molfetta1, Alessandra Zingoni1, Alessandra Soriani1, Marco Cippitelli1, Rossella Paolini1, Angela Gismondi1, Maria Rosaria Ricciardi2, Maria Teresa Petrucci2, Laura Masuelli3, Giulio Caracciolo1, Sara Palchetti1, Angela Santoni1,4, Cinzia Fionda1.
Abstract
Bone marrow stromal cells (BMSCs) strongly contribute to multiple myeloma (MM) progression, promoting the survival and growth of malignant plasma cells (PCs). However, the possible impact of these cells on the immune-mediated recognition of MM cells remains largely unknown. DNAM-1 activating receptor plays a prominent role in NK cell anti-MM response engaging the ligands poliovirus receptor (PVR) and nectin-2 on malignant PCs. Here, we analysed the role of MM patient-derived BMSCs in the regulation of PVR expression. We found that BMSCs enhance PVR surface expression on MM cells and promote their NK cell-mediated recognition. PVR upregulation occurs at transcriptional level and involves NF-kB transcription factor activation by BMSC-derived soluble factors. Indeed, overexpression of a dominant-negative mutant of IKBα blocked PVR upregulation. IL-8 plays a prominent role in these mechanisms since blockade of CXCR1/2 receptors as well as depletion of the cytokine via RNA interference prevents the enhancement of PVR expression by BMSC-derived conditioned medium. Interestingly, IL-8 is associated with stromal microvesicles which are also required for PVR upregulation via CXCR1/CXCR2 signaling activation. Our findings identify BMSCs as regulators of NK cell anti-MM response and contribute to define novel molecular pathways involved in the regulation of PVR expression in cancer cells.Entities:
Keywords: IL-8; PVR; bone marrow stromal cells; multiple myeloma; natural killer cells
Year: 2020 PMID: 32069911 DOI: 10.3390/cancers12020440
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639